Nosocomial fungemia due to exophiala jeanselmei var. jeanselmei and a Rhinocladiella species: Newly described causes of bloodstream infection

M. Nucci, T. Akiti, G. Barreiros, F. Silveira, S. G. Revankar, D. A. Sutton, Thomas F Patterson

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Fungi have become increasingly important causes of nosocomial bloodstream infections. The major cause of nosocomial fungemia has been Candida spp, but increasingly molds and other yeasts have caused disease. Exophiala jeanselmei and members of the genus Rhinocladiella are dematiaceous moulds, which have been infrequently associated with systemic infection and have not been described as causes of fungemia. In this paper, the occurrence of 23 cases of fungemia due to these organisms over a 10-month period is reported and the clinical characteristics of patients and outcomes are described. The majority of patients were immuno-suppressed; 21 of 23 (91%) had received blood products and 78% had a central venous catheter. All patients had at least one manifestation of fever, but only one patient had signs or symptoms suggesting deep-seated infection. Antifungal therapy was given to 19 of the 23 patients; of those who did not receive therapy, 3 died prior to the culture result and 1 had been discharged without therapy. Antifungal susceptibility of the organisms showed activity of amphotericin B, itraconazole, and the new triazole antifungals voriconazole and posaconazole. E. jeanselmei and Rhinocladiella species are potential causes of nosocomial fungemia and may be associated with systemic infection.

Original languageEnglish (US)
Pages (from-to)514-518
Number of pages5
JournalJournal of Clinical Microbiology
Volume39
Issue number2
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Exophiala
Fungemia
Infection
Fungi
Triazoles
Itraconazole
Central Venous Catheters
Amphotericin B
Cross Infection
Candida
Signs and Symptoms
Fever
Therapeutics
Yeasts

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Nosocomial fungemia due to exophiala jeanselmei var. jeanselmei and a Rhinocladiella species : Newly described causes of bloodstream infection. / Nucci, M.; Akiti, T.; Barreiros, G.; Silveira, F.; Revankar, S. G.; Sutton, D. A.; Patterson, Thomas F.

In: Journal of Clinical Microbiology, Vol. 39, No. 2, 2001, p. 514-518.

Research output: Contribution to journalArticle

Nucci, M. ; Akiti, T. ; Barreiros, G. ; Silveira, F. ; Revankar, S. G. ; Sutton, D. A. ; Patterson, Thomas F. / Nosocomial fungemia due to exophiala jeanselmei var. jeanselmei and a Rhinocladiella species : Newly described causes of bloodstream infection. In: Journal of Clinical Microbiology. 2001 ; Vol. 39, No. 2. pp. 514-518.
@article{07bf0609ba0e48d3b64410b85cd45eea,
title = "Nosocomial fungemia due to exophiala jeanselmei var. jeanselmei and a Rhinocladiella species: Newly described causes of bloodstream infection",
abstract = "Fungi have become increasingly important causes of nosocomial bloodstream infections. The major cause of nosocomial fungemia has been Candida spp, but increasingly molds and other yeasts have caused disease. Exophiala jeanselmei and members of the genus Rhinocladiella are dematiaceous moulds, which have been infrequently associated with systemic infection and have not been described as causes of fungemia. In this paper, the occurrence of 23 cases of fungemia due to these organisms over a 10-month period is reported and the clinical characteristics of patients and outcomes are described. The majority of patients were immuno-suppressed; 21 of 23 (91{\%}) had received blood products and 78{\%} had a central venous catheter. All patients had at least one manifestation of fever, but only one patient had signs or symptoms suggesting deep-seated infection. Antifungal therapy was given to 19 of the 23 patients; of those who did not receive therapy, 3 died prior to the culture result and 1 had been discharged without therapy. Antifungal susceptibility of the organisms showed activity of amphotericin B, itraconazole, and the new triazole antifungals voriconazole and posaconazole. E. jeanselmei and Rhinocladiella species are potential causes of nosocomial fungemia and may be associated with systemic infection.",
author = "M. Nucci and T. Akiti and G. Barreiros and F. Silveira and Revankar, {S. G.} and Sutton, {D. A.} and Patterson, {Thomas F}",
year = "2001",
doi = "10.1128/JCM.39.2.514-518.2001",
language = "English (US)",
volume = "39",
pages = "514--518",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Nosocomial fungemia due to exophiala jeanselmei var. jeanselmei and a Rhinocladiella species

T2 - Newly described causes of bloodstream infection

AU - Nucci, M.

AU - Akiti, T.

AU - Barreiros, G.

AU - Silveira, F.

AU - Revankar, S. G.

AU - Sutton, D. A.

AU - Patterson, Thomas F

PY - 2001

Y1 - 2001

N2 - Fungi have become increasingly important causes of nosocomial bloodstream infections. The major cause of nosocomial fungemia has been Candida spp, but increasingly molds and other yeasts have caused disease. Exophiala jeanselmei and members of the genus Rhinocladiella are dematiaceous moulds, which have been infrequently associated with systemic infection and have not been described as causes of fungemia. In this paper, the occurrence of 23 cases of fungemia due to these organisms over a 10-month period is reported and the clinical characteristics of patients and outcomes are described. The majority of patients were immuno-suppressed; 21 of 23 (91%) had received blood products and 78% had a central venous catheter. All patients had at least one manifestation of fever, but only one patient had signs or symptoms suggesting deep-seated infection. Antifungal therapy was given to 19 of the 23 patients; of those who did not receive therapy, 3 died prior to the culture result and 1 had been discharged without therapy. Antifungal susceptibility of the organisms showed activity of amphotericin B, itraconazole, and the new triazole antifungals voriconazole and posaconazole. E. jeanselmei and Rhinocladiella species are potential causes of nosocomial fungemia and may be associated with systemic infection.

AB - Fungi have become increasingly important causes of nosocomial bloodstream infections. The major cause of nosocomial fungemia has been Candida spp, but increasingly molds and other yeasts have caused disease. Exophiala jeanselmei and members of the genus Rhinocladiella are dematiaceous moulds, which have been infrequently associated with systemic infection and have not been described as causes of fungemia. In this paper, the occurrence of 23 cases of fungemia due to these organisms over a 10-month period is reported and the clinical characteristics of patients and outcomes are described. The majority of patients were immuno-suppressed; 21 of 23 (91%) had received blood products and 78% had a central venous catheter. All patients had at least one manifestation of fever, but only one patient had signs or symptoms suggesting deep-seated infection. Antifungal therapy was given to 19 of the 23 patients; of those who did not receive therapy, 3 died prior to the culture result and 1 had been discharged without therapy. Antifungal susceptibility of the organisms showed activity of amphotericin B, itraconazole, and the new triazole antifungals voriconazole and posaconazole. E. jeanselmei and Rhinocladiella species are potential causes of nosocomial fungemia and may be associated with systemic infection.

UR - http://www.scopus.com/inward/record.url?scp=0035126728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035126728&partnerID=8YFLogxK

U2 - 10.1128/JCM.39.2.514-518.2001

DO - 10.1128/JCM.39.2.514-518.2001

M3 - Article

C2 - 11158099

AN - SCOPUS:0035126728

VL - 39

SP - 514

EP - 518

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 2

ER -